Surveillance Study of NovoRapid® for New Drug Re-examination

Update Il y a 4 ans
Reference: NCT01490112

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This study is conducted in Asia. The aim of this study is to observe the safety and efficacy of insulin aspart (NovoRapid®) administered via vial and three different devices.


Inclusion criteria

  • diabetes,Diabetes Mellitus, Type 1,Diabetes Mellitus, Type 2

Links